
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT
- About


Alphatec Holdings Inc (ATEC)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/17/2025: ATEC (1-star) is a SELL. SELL since 1 days. Simulated Profits (-4.17%). Updated daily EoD!
1 Year Target Price $18.95
1 Year Target Price $18.95
4 | Strong Buy |
5 | Buy |
1 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 3.61% | Avg. Invested days 34 | Today’s Advisory SELL |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.18B USD | Price to earnings Ratio - | 1Y Target Price 18.95 |
Price to earnings Ratio - | 1Y Target Price 18.95 | ||
Volume (30-day avg) 10 | Beta 1.03 | 52 Weeks Range 4.88 - 16.70 | Updated Date 09/17/2025 |
52 Weeks Range 4.88 - 16.70 | Updated Date 09/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.13 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -24.33% | Operating Margin (TTM) -6.19% |
Management Effectiveness
Return on Assets (TTM) -7.61% | Return on Equity (TTM) -376.89% |
Valuation
Trailing PE - | Forward PE 33.44 | Enterprise Value 2653762138 | Price to Sales(TTM) 3.19 |
Enterprise Value 2653762138 | Price to Sales(TTM) 3.19 | ||
Enterprise Value to Revenue 3.89 | Enterprise Value to EBITDA -18.89 | Shares Outstanding 147983775 | Shares Floating 116377400 |
Shares Outstanding 147983775 | Shares Floating 116377400 | ||
Percent Insiders 20.78 | Percent Institutions 69.11 |
Upturn AI SWOT
Alphatec Holdings Inc

Company Overview
History and Background
Alphatec Holdings Inc. (ATEC) was founded in 2006. The company focuses on developing, manufacturing, and marketing spinal implant products and surgical instruments. It has grown through acquisitions and organic product development.
Core Business Areas
- Spinal Implants: ATEC designs, develops, and markets a comprehensive line of spinal implant products used in spinal fusion surgery for the treatment of spinal disorders.
- Surgical Instruments: ATEC provides a variety of surgical instruments for use during spinal surgery.
- Biologics: ATEC offers biologic solutions to promote spinal fusion.
- Navigation and Robotics: ATEC offers surgical navigation and robotics technologies to enhance surgical precision and efficiency.
Leadership and Structure
ATEC is led by Patrick Miles, Chairman and CEO. The organizational structure consists of various departments including R&D, marketing, sales, and operations.
Top Products and Market Share
Key Offerings
- Safe-Lock Plating System: A comprehensive plating system used in anterior cervical discectomy and fusion (ACDF) procedures. Market share information for specific plating systems is not readily available, but ATEC competes with Medtronic, Stryker, and Johnson & Johnson in the broader cervical plating market.
- Invictus Spinal Fixation System: A pedicle screw system designed for posterior spinal fixation. Market share data is not publicly available. Competitors include Medtronic, Nuvasive, and Globus Medical.
- EOS Imaging System: EOS imaging technology offers weight-bearing, low-dose full-body images for musculoskeletal conditions. Market share data is not readily available but competitors include Siemens Healthineers and GE Healthcare in imaging solutions.
- ALPHA Navigation System: ALPHA Navigation System offers precise surgical navigation capabilities, enhancing accuracy and efficiency during spine procedures. Key competitors include Medtronic's StealthStation and Globus Medical's ExcelsiusGPS, but specific market share data for navigation systems is not publicly available.
Market Dynamics
Industry Overview
The spinal implant market is driven by an aging population, increasing prevalence of spinal disorders, and technological advancements in surgical techniques. The industry is highly competitive and subject to regulatory scrutiny.
Positioning
ATEC is a mid-sized player in the spinal implant market, focusing on innovation and strategic acquisitions to gain market share. Its competitive advantage lies in its comprehensive product portfolio and focus on advanced technologies.
Total Addressable Market (TAM)
The global spine market is estimated to be approximately $10 billion. ATEC aims to increase its market share through product innovation and strategic partnerships, positioning itself to capture a larger portion of the TAM.
Upturn SWOT Analysis
Strengths
- Comprehensive Product Portfolio
- Focus on Technological Innovation
- Strategic Acquisitions
- Strong Surgeon Relationships
Weaknesses
- Smaller Market Share Compared to Larger Competitors
- Dependence on Key Products
- History of net losses
Opportunities
- Expanding Product Portfolio Through R&D
- Geographic Expansion into Emerging Markets
- Increased Adoption of Minimally Invasive Surgery (MIS)
- Strategic Partnerships and Collaborations
Threats
- Intense Competition
- Pricing Pressure
- Regulatory Changes
- Product Liability Litigation
Competitors and Market Share
Key Competitors
- Medtronic (MDT)
- Stryker (SYK)
- Johnson & Johnson (JNJ)
- Globus Medical (GMED)
- Nuvasive (NUVA)
Competitive Landscape
ATEC is a smaller player compared to the larger competitors like Medtronic and Stryker. ATEC focuses on innovation and strategic acquisitions to differentiate itself. Its advantage is its comprehensive portfolio and surgeon relationships; its disadvantage is its smaller scale.
Major Acquisitions
EOS imaging
- Year: 2018
- Acquisition Price (USD millions): 96.4
- Strategic Rationale: Acquisition of EOS imaging provides ATEC with advanced imaging technology to enhance surgical planning and outcomes.
Growth Trajectory and Initiatives
Historical Growth: ATEC has experienced significant revenue growth over the past several years, driven by product innovation and strategic acquisitions.
Future Projections: Analyst estimates project continued revenue growth, but profitability remains a challenge. Future growth depends on successful product launches and effective cost management.
Recent Initiatives: Recent initiatives include launching new spinal implant products, expanding the sales force, and investing in robotic and navigation technologies.
Summary
Alphatec Holdings shows promise with revenue growth driven by innovation and acquisitions. While they are a smaller player compared to competitors, strategic efforts focus on technological advancement to improve competitive positioning. Profitability remains a challenge; effective cost management and continued innovation are critical. The company must navigate competitive pressures and regulatory changes.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings (10-K, 10-Q)
- Investor Presentations
- Press Releases
- Analyst Reports
- Market Research Reports
Disclaimers:
The data and analysis provided are based on publicly available information and analyst estimates, and are subject to change. This is not financial advice. Consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Alphatec Holdings Inc
Exchange NASDAQ | Headquaters Carlsbad, CA, United States | ||
IPO Launch date 2006-06-02 | Executive Chairman, CEO & President Mr. Patrick S. Miles | ||
Sector Healthcare | Industry Medical Devices | Full time employees 867 | Website https://www.atecspine.com |
Full time employees 867 | Website https://www.atecspine.com |
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants and instruments. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.